RSS   Newsletter   Contact   Advertise with us
Post Online Media

Xenetic Biosciences appoints director

XeneticXenetic Biosciences, a biopharmaceutical company, announced that it has appointed Edward J. Benz, Jr. to the board of directors.

Dr. Benz is a renowned expert in blood disorders and is board certified in both hematology and internal medicine.

Article continues below

READ MORE Xenetic Biosciences chairman Mark Leuchtenberger resigns

Dr. Benz is an active clinical hematologist and a National Institutes of Health (NIH) funded researcher with a focus on the molecular basis and genetics around inherited blood disorders.

Prior to joining the Xenetic Board, Dr. Benz served as President and CEO Emeritus of Dana-Farber Cancer Institute and the Richard and Susan Smith Professor of Medicine and Professor of Genetics at Harvard Medical School.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy